NGNE Insider Trading Activity and SEC Form 4 Filings
NGNE insider trading summary
Over the past 12 months, insiders at Neurogene Inc. (NGNE) reported 14 sales worth $986K by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $986K.
Latest NGNE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $152K (4,200 @ $36.13) |
| Jul 6, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $22K (600 @ $36.02) |
| Jul 2, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $88K (2,531 @ $34.58) |
| Jul 2, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $54K (1,530 @ $35.23) |
| Jul 1, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $25K (739 @ $34.06) |
| May 6, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $144K (4,800 @ $30.07) |
| May 6, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $156K (4,800 @ $32.44) |
| Mar 13, 2026 | Stuart Cobb | Chief Scientific Officer | Sell | $57K (2,658 @ $21.34) |
| Mar 13, 2026 | Stuart Cobb | Chief Scientific Officer | Sell | $3K (148 @ $22.08) |
| Mar 13, 2026 | Christine Mikail Cvijic | President and CFO | Sell | $30K (1,395 @ $21.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.